Medicare Enrolled
Dr. Sherry Sinclair, M.D.
Optician · Raleigh, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sinclair from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sinclair?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sinclair
Dr. Sherry Sinclair is an optician specialist in Raleigh, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sinclair performed 79,378 Medicare services across 1,955 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sinclair received a total of $17,454 from 42 pharmaceutical and/or device companies across 920 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sinclair is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NC
$17,454 industry payments
Medicare Practice Summary
Medicare Utilization ↗79,378
Medicare services
Top 1% in NC for optician
1,955
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,969 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
56,000 | $4 | $9 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
11,750 | $34 | $61 |
| Denosumab injection (Prolia/Xgeva) | 4,440 | $18 | $25 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
2,920 | $26 | $101 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
745 | $1 | $62 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
661 | $83 | $156 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
264 | $8 | $40 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
213 | $46 | $170 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
210 | $6 | $200 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
179 | $21 | $84 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
165 | $57 | $121 |
| Liver function blood test panel | 163 | $8 | $60 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
161 | $5 | $24 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
161 | $18 | $30 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
160 | $96 | $250 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
156 | $16 | $73 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
133 | $10 | $20 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
125 | $1 | $15 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
117 | $5 | $46 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
110 | $4 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
83 | $11 | $71 |
| New patient office visit, complex (60-74 min) | 69 | $150 | $297 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
57 | $135 | $207 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
48 | $29 | $65 |
| Immunoassay substance analysis, multiple step method A laboratory test that uses an immunoassay technique to analyze a substance. The process involves multiple steps to detect or measure the target material. |
48 | $11 | $30 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
42 | $35 | $210 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
36 | $44 | $127 |
| Tuberculosis blood test (gamma interferon) A blood test that measures the immune system's response to tuberculosis bacteria using gamma interferon levels. |
36 | $61 | $130 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
32 | $8 | $11 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
24 | $13 | $30 |
| Rheumatoid factor level | 24 | $6 | $18 |
| DNA antibody test (native or double-stranded) A blood test that measures the level of antibodies targeting native or double-stranded DNA. This test is used to detect the presence of these specific antibodies in the body. |
23 | $13 | $55 |
| Measurement of dna antibody, single stranded | 23 | $12 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.9% high complexity
76.9% medium
3.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,454
Total received (2018-2024)
Avg $2,493/year across 7 years
Top 8% in NC for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
920
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,340 (99.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$114 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,611
2023
$1,151
2022
$3,067
2021
$2,855
2020
$2,542
2019
$3,200
2018
$3,027
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$370
GlaxoSmithKline, LLC.
$260
Amgen Inc.
$204
AstraZeneca Pharmaceuticals LP
$152
PFIZER INC.
$112
Boehringer Ingelheim Pharmaceuticals, Inc.
$96
UCB, Inc.
$84
Novartis Pharmaceuticals Corporation
$82
Janssen Biotech, Inc.
$69
E.R. Squibb & Sons, L.L.C.
$41
GENZYME CORPORATION
$31
Organon Llc
$29
Celgene Corporation
$23
Aurinia Pharma U.S., Inc.
$21
Lilly USA, LLC
$20
Sandoz Inc.
$19
Top 3 companies account for 51.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$2,444
UCB, Inc.
$1,564
PFIZER INC.
$1,446
Janssen Biotech, Inc.
$1,299
GlaxoSmithKline, LLC.
$1,244
Radius Health, Inc.
$957
AbbVie, Inc.
$850
Horizon Therapeutics plc
$835
AbbVie Inc.
$664
Regeneron Healthcare Solutions, Inc.
$664
ABBVIE INC.
$652
E.R. Squibb & Sons, L.L.C.
$588
Lilly USA, LLC
$550
Celgene Corporation
$544
Novartis Pharmaceuticals Corporation
$534
Genentech USA, Inc.
$393
AstraZeneca Pharmaceuticals LP
$357
Boehringer Ingelheim Pharmaceuticals, Inc.
$256
Mallinckrodt Hospital Products Inc.
$189
NOVARTIS PHARMACEUTICALS CORPORATION
$182
Alexion Pharmaceuticals, Inc.
$172
Horizon Pharma plc
$137
Sobi, Inc
$130
Hikma Pharmaceuticals USA
$109
Mallinckrodt LLC
$107
GENZYME CORPORATION
$93
Organon LLC
$83
Boston Scientific Corporation
$57
Mallinckrodt Enterprises LLC
$43
Aurinia Pharma U.S., Inc.
$40
Merck Sharp & Dohme Corporation
$39
MEDAC PHARMA, INC.
$33
Bioventus LLC
$33
Takeda Pharmaceuticals U.S.A., Inc.
$32
Organon Llc
$29
MEDEXUS PHARMA, INC.
$24
Sandoz Inc.
$19
Ironwood Pharmaceuticals, Inc
$16
DePuy Synthes Sales Inc.
$13
West-Ward Pharmaceuticals
$13
Zyla Life Sciences
$12
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · DUEXIS · DUZALLO · Durolane · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Horizant · Humira · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · MONOVISC · Mitigare · OFEV · ORENCIA · Otezla · PENNSAID · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · Uloric · Ultomiris · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for optician in NC.
Geographic Context
Opticians within 10 mi
236
Per 100K population
20.5
County median income
$101,763
Nearest hospital
REX HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sinclair is a mixed practice specialist, with above-average Medicare volume (top 1% in NC), with low-engagement industry engagement in the top 8% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sinclair experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Sinclair performed 56,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sinclair receive payments from pharmaceutical companies?
Yes. Dr. Sinclair received a total of $17,454 from 42 companies across 920 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sinclair's costs compare to other opticians in Raleigh?
Dr. Sinclair's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sinclair) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Raleigh
Browse opticians in Raleigh ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NC
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NC
Which NC opticians receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology